IBUPROFEN SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Ibuprofen Sodium patents expire, and what generic alternatives are available?
Ibuprofen Sodium is a drug marketed by Perrigo R And D and is included in one NDA.
The generic ingredient in IBUPROFEN SODIUM is ibuprofen sodium. There are sixty-four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ibuprofen sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for IBUPROFEN SODIUM?
- What are the global sales for IBUPROFEN SODIUM?
- What is Average Wholesale Price for IBUPROFEN SODIUM?
Summary for IBUPROFEN SODIUM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 45 |
| Clinical Trials: | 39 |
| Patent Applications: | 4,247 |
| DailyMed Link: | IBUPROFEN SODIUM at DailyMed |
Recent Clinical Trials for IBUPROFEN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| CMC Ambroise Paré | N/A |
| Ajman University | Phase 4 |
| Universitat Internacional de Catalunya | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for IBUPROFEN SODIUM
US Patents and Regulatory Information for IBUPROFEN SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Perrigo R And D | IBUPROFEN SODIUM | ibuprofen sodium | TABLET;ORAL | 206581-001 | Aug 3, 2015 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
